These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

372 related articles for article (PubMed ID: 16353949)

  • 1. Regulation of monoamine transporters: influence of psychostimulants and therapeutic antidepressants.
    Jayanthi LD; Ramamoorthy S
    AAPS J; 2005 Oct; 7(3):E728-38. PubMed ID: 16353949
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Recognition of psychostimulants, antidepressants, and other inhibitors of synaptic neurotransmitter uptake by the plasma membrane monoamine transporters.
    Surratt CK; Ukairo OT; Ramanujapuram S
    AAPS J; 2005 Oct; 7(3):E739-51. PubMed ID: 16353950
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role of monoamine transporters in mediating psychostimulant effects.
    Riddle EL; Fleckenstein AE; Hanson GR
    AAPS J; 2005 Dec; 7(4):E847-51. PubMed ID: 16594636
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Monoamine neurocircuitry in depression and strategies for new treatments.
    Hamon M; Blier P
    Prog Neuropsychopharmacol Biol Psychiatry; 2013 Aug; 45():54-63. PubMed ID: 23602950
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A kinome wide screen identifies novel kinases involved in regulation of monoamine transporter function.
    Vuorenpää A; Ammendrup-Johnsen I; Jørgensen TN; Gether U
    Neurochem Int; 2016 Sep; 98():103-14. PubMed ID: 27020406
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Monoamine transporters and psychostimulant addiction.
    Howell LL; Kimmel HL
    Biochem Pharmacol; 2008 Jan; 75(1):196-217. PubMed ID: 17825265
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neurotransmitter transporters and their impact on the development of psychopharmacology.
    Iversen L
    Br J Pharmacol; 2006 Jan; 147 Suppl 1(Suppl 1):S82-8. PubMed ID: 16402124
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Regulation of the Dopamine and Vesicular Monoamine Transporters: Pharmacological Targets and Implications for Disease.
    German CL; Baladi MG; McFadden LM; Hanson GR; Fleckenstein AE
    Pharmacol Rev; 2015 Oct; 67(4):1005-24. PubMed ID: 26408528
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Monoamine transporter as a target molecule for psychostimulants.
    Sora I; Li B; Fumushima S; Fukui A; Arime Y; Kasahara Y; Tomita H; Ikeda K
    Int Rev Neurobiol; 2009; 85():29-33. PubMed ID: 19607959
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of the monoamine transporters from human and mouse in their sensitivities to psychostimulant drugs.
    Han DD; Gu HH
    BMC Pharmacol; 2006 Mar; 6():6. PubMed ID: 16515684
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Psychostimulants and monoamine transporters: upsetting the balance.
    Elliott JM; Beveridge TJ
    Curr Opin Pharmacol; 2005 Feb; 5(1):94-100. PubMed ID: 15661632
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Regulation of monoamine transporters: Role of transporter phosphorylation.
    Ramamoorthy S; Shippenberg TS; Jayanthi LD
    Pharmacol Ther; 2011 Feb; 129(2):220-38. PubMed ID: 20951731
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The profile of mephedrone on human monoamine transporters differs from 3,4-methylenedioxymethamphetamine primarily by lower potency at the vesicular monoamine transporter.
    Pifl C; Reither H; Hornykiewicz O
    Eur J Pharmacol; 2015 May; 755():119-26. PubMed ID: 25771452
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Pharmacology of monoamine neurotransmitter transporters].
    Dohi T; Kitayama S; Kumagai K; Hashimoto W; Morita K
    Nihon Yakurigaku Zasshi; 2002 Nov; 120(5):315-26. PubMed ID: 12491807
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Monoamine transporters and psychostimulant drugs.
    Rothman RB; Baumann MH
    Eur J Pharmacol; 2003 Oct; 479(1-3):23-40. PubMed ID: 14612135
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Function of monoamine neurotransmitter transporters].
    Sasa M
    Nihon Rinsho; 2001 Aug; 59(8):1457-64. PubMed ID: 11519142
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Localization and dynamic regulation of biogenic amine transporters in the mammalian central nervous system.
    Hoffman BJ; Hansson SR; Mezey E; Palkovits M
    Front Neuroendocrinol; 1998 Jul; 19(3):187-231. PubMed ID: 9665836
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expression cloning of a serotonin transporter: a new way to study antidepressant drugs.
    Hoffman BJ
    Pharmacopsychiatry; 1994 Jan; 27(1):16-22. PubMed ID: 8159777
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Monoamine transporter and receptor interaction profiles of novel psychoactive substances: para-halogenated amphetamines and pyrovalerone cathinones.
    Rickli A; Hoener MC; Liechti ME
    Eur Neuropsychopharmacol; 2015 Mar; 25(3):365-76. PubMed ID: 25624004
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Phosphorylation and regulation of psychostimulant-sensitive neurotransmitter transporters.
    Vaughan RA
    J Pharmacol Exp Ther; 2004 Jul; 310(1):1-7. PubMed ID: 15064332
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.